InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: jsc52033 post# 235202

Tuesday, 07/24/2018 11:41:21 AM

Tuesday, July 24, 2018 11:41:21 AM

Post# of 403022
I am adding some qualifiers to ffrol posting.

Assuming that phase 2b trial is successful and shows at least the same efficacy as phase 2a trial did. Then

1. Oral adminstration
2. More effective than most other non-biological treatments for psoriasis. Depending on the level where prurisol efficacy settles at, methotrexate (cytotoxin) or cyclosporine (IARC Group 1 carcinogen) might still be more effective.
3. With proper patient screening (some people are allergic to abacavir which is the main metabolite of prurisol) has few side-effects (definitely less than methotrexate, cyclosporine or Otezla) and, so far, no evidence of immunosuppression which is the major concern with almost all biologicals.
4. Currently no evidence of the loss of effectiveness over time.

"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News